Cargando…
FRI493 Immune Checkpoint Inhibitors: Effects On Thyroid Nodular Disease
Disclosure: D.L. Bignoli: None. N. Kalara: None. A.J. Manzano: None. Introduction: Immune checkpoint inhibitors (ICI) are more recent pharmacologic agents used to treat malignancies, linked to immune related adverse events (irAEs) especially involving the thyroid. Classically, a transient silent thy...
Autores principales: | Maria Bignoli, Daniela Laura, Kalara, Niketa, Manzano, Alex J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555034/ http://dx.doi.org/10.1210/jendso/bvad114.1839 |
Ejemplares similares
-
SAT493 Laser Ablation For Benign Thyroid Nodules: A Way To Treat And Still Preserve The Thyroid
por: Kalara, Niketa, et al.
Publicado: (2023) -
FRI489 The Interplay Between Thyroid Nodular Disease And Insulin Resistance Indices In Pregnant Women
por: Jerzy Nowak, Andrzej, et al.
Publicado: (2023) -
SAT-493 A Case of Profound Hypothyroidism Secondary to Immune Check Point Inhibitors
por: Tun, Yin Nwe, et al.
Publicado: (2020) -
FRI539 Vitamin D and Endocrine Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors
por: He, Zijun, et al.
Publicado: (2023) -
ODP493 Malignant Struma Ovarii with Papillary Thyroid Carcinoma and concomitant High Risk Thyroid Nodule
por: Chaidarun, Tanyawan, et al.
Publicado: (2022)